140911-31-5 Usage
Description
8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE is a halogenated heterocyclic compound belonging to the triazolopyrazine family. It features a chlorine atom and a trifluoromethyl group, which may contribute to its unique chemical and biological properties. Known for their diverse pharmacological activities, triazolopyrazines serve as valuable building blocks in the development of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE is used as a building block for the development of pharmaceuticals due to its unique chemical and biological properties. Its presence in the triazolopyrazine family allows for the creation of compounds with diverse pharmacological activities, making it a promising candidate for various therapeutic applications.
Used in Agrochemical Industry:
8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE is used as a building block for the development of agrochemicals, leveraging its unique properties to create compounds with potential applications in agriculture, such as pesticides or herbicides. Its role in this industry is to contribute to the creation of effective and environmentally friendly solutions for crop protection and management.
Check Digit Verification of cas no
The CAS Registry Mumber 140911-31-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,0,9,1 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 140911-31:
(8*1)+(7*4)+(6*0)+(5*9)+(4*1)+(3*1)+(2*3)+(1*1)=95
95 % 10 = 5
So 140911-31-5 is a valid CAS Registry Number.
140911-31-5Relevant articles and documents
Triazolo pyrazine compound containing heteroaryl substituted pyridazinone structure, and preparation method and applications thereof
-
, (2019/11/29)
The invention relates to a triazolo pyrazine compound containing a heteroaryl substituted pyridazinone structure, and pharmaceutically acceptable salts, hydrates, solvates, and a prodrug thereof, wherein the triazolo pyrazine compound containing a heteroa
FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 60, (2008/06/13)
The present invention is directed to novel fused triazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
